Cytosorbents (CTSO) Asset Utilization Ratio (2012 - 2026)
Cytosorbents' (CTSO) quarterly Asset Utilization Ratio came in at 0.95 in Q2 2026, up 29.65% on a YoY basis from 0.73 in Q2 2025, and up 7.97% quarter-over-quarter from 0.88 in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Asset Utilization Ratio for 14 consecutive years, with 0.95 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Utilization Ratio rose 29.65% year-over-year to 0.95; the trailing twelve-month figure through Jun 2026 stood at 0.95 (up 29.65% YoY), and the FY2025 full-year result was 0.81, up 14.1% from the prior year.
- Asset Utilization Ratio improved to 0.95 in Q2 2026 per CTSO's latest filing, from 0.88 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.95 in Q2 2026 and bottomed at 0.48 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.7 across 5 years, with a median of 0.72 in 2025.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio jumped 37.11% in 2023, then fell 6.42% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.55 in 2022, then soared by 30.81% to 0.72 in 2023, then grew by 3.44% to 0.75 in 2024, then increased by 10.19% to 0.82 in 2025, then climbed by 15.0% to 0.95 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.95, 0.88, and 0.82 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.42 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 0.54 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 0.40 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 0.55 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.47 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.48 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.34 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 0.76 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 0.56 |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 0.95 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.95 |
| Mar 31, 2026 | 0.88 |
| Dec 31, 2025 | 0.82 |
| Sep 30, 2025 | 0.79 |
| Jun 30, 2025 | 0.73 |
| Mar 31, 2025 | 0.72 |
| Dec 31, 2024 | 0.75 |
| Sep 30, 2024 | 0.69 |
| Jun 30, 2024 | 0.70 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.72 |
| Sep 30, 2023 | 0.74 |
| Jun 30, 2023 | 0.66 |
| Mar 31, 2023 | 0.59 |
| Dec 31, 2022 | 0.55 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.49 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.46 |